Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Characterisation of K+ channels in human fetoplacental vascular smooth muscle cells.

Brereton MF, Wareing M, Jones RL, Greenwood SL.

PLoS One. 2013;8(2):e57451. doi: 10.1371/journal.pone.0057451.

2.

Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Félétou M.

Br J Pharmacol. 2009 Feb;156(4):545-62. doi: 10.1111/j.1476-5381.2009.00052.x. Review.

3.

Detection and implications of potassium channel alterations.

Korovkina VP, England SK.

Vascul Pharmacol. 2002 Jan;38(1):3-12. Review.

PMID:
12378820
4.
5.

Involvement of potassium channels in the progression of cancer to a more malignant phenotype.

Comes N, Serrano-Albarrás A, Capera J, Serrano-Novillo C, Condom E, Ramón Y Cajal S, Ferreres JC, Felipe A.

Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2477-92. doi: 10.1016/j.bbamem.2014.12.008. Review.

6.

Function and regulation of large conductance Ca(2+)-activated K+ channel in vascular smooth muscle cells.

Hu XQ, Zhang L.

Drug Discov Today. 2012 Sep;17(17-18):974-87. doi: 10.1016/j.drudis.2012.04.002. Review.

7.

What do we not know about mitochondrial potassium channels?

Laskowski M, Augustynek B, Kulawiak B, Koprowski P, Bednarczyk P, Jarmuszkiewicz W, Szewczyk A.

Biochim Biophys Acta. 2016 Aug;1857(8):1247-57. doi: 10.1016/j.bbabio.2016.03.007. Review.

PMID:
26951942
8.

New tricks for old dogs: KCNQ expression and role in smooth muscle.

Greenwood IA, Ohya S.

Br J Pharmacol. 2009 Apr;156(8):1196-203. doi: 10.1111/j.1476-5381.2009.00131.x. Review.

9.

KCNQ potassium channels: new targets for pulmonary vasodilator drugs?

Gurney AM, Joshi S, Manoury B.

Adv Exp Med Biol. 2010;661:405-17. doi: 10.1007/978-1-60761-500-2_26. Review.

PMID:
20204745
10.

α-Smooth Muscle Actin and ACTA2 Gene Expressions in Vasculopathies.

Yuan SM.

Braz J Cardiovasc Surg. 2015 Nov-Dec;30(6):644-9. doi: 10.5935/1678-9741.20150081. Review.

11.

Regulation of fetoplacental vascular bed by hypoxia.

Hampl V, Jakoubek V.

Physiol Res. 2009;58 Suppl 2:S87-93. Review.

12.

K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders.

Stott JB, Jepps TA, Greenwood IA.

Drug Discov Today. 2014 Apr;19(4):413-24. doi: 10.1016/j.drudis.2013.12.003. Review.

PMID:
24333708
Items per page

Supplemental Content

Support Center